General
Corporate
December 3, 2024
WERFEN EXPANDS HEMOSTASIS AND ACUTE CARE DIAGNOSTICS TECHNOLOGY CENTER IN BEDFORD, MA
...
Corporate
July 15, 2024 - Barcelona, Spain
Werfen expands its Board of Directors, adds two new members
...
Corporate
May 15, 2024 - Barcelona, Spain
Werfen to acquire Omixon, expanding its portfolio in transplant diagnostics
...
Corporate
April 26, 2024 - Barcelona, Spain
Werfen completes a new €500 million, 6-year bond issue
...
Corporate
April 15, 2024 - Barcelona, Spain
WERFEN TO DIVEST MEDICAL DEVICES AND SCIENTIFIC INSTRUMENTATION DISTRIBUTION BUSINESSES TO PALEX
...
Corporate
September 7, 2023
Werfen launches We Venture Capital to invest in disruptive technologies that will shape the future of diagnostics.
...
Corporate
May 26, 2023 - Barcelona, Spain
Werfen successfully completes a new 5-year bond issue for €500 million
...
Corporate
March 15, 2023 - Barcelona, Spain
Werfen completes acquisition of Immucor, Inc., expanding leadership in Specialized Diagnostics
...
Corporate
Corporate
December 17, 2018 - Barcelona
Presidency handover at Werfen, world leader in in vitro diagnostics
...
